Depression — The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Citation(s)
Allen JJ, Urry HL, Hitt SK, Coan JA The stability of resting frontal electroencephalographic asymmetry in depression. Psychophysiology. 2004 Mar;41(2):269-80.
Callaghan P, Khalil E, Morres I, Carter T Pragmatic randomised controlled trial of preferred intensity exercise in women living with depression. BMC Public Health. 2011 Jun 12;11:465. doi: 10.1186/1471-2458-11-465.
Chaouloff F, Elghozi JL, Guezennec Y, Laude D Effects of conditioned running on plasma, liver and brain tryptophan and on brain 5-hydroxytryptamine metabolism of the rat. Br J Pharmacol. 1985 Sep;86(1):33-41.
Lande, G R., Banks-Williams, L., & Fileta, B. (2012). The forensic assessment of combat-related irritability with whole blood serotonin levels: a pilot study. The Journal of Forensic Psychiatry & Psychology, 23(5-6). 654-663.
Perraton LG, Kumar S, Machotka Z Exercise parameters in the treatment of clinical depression: a systematic review of randomized controlled trials. J Eval Clin Pract. 2010 Jun;16(3):597-604. doi: 10.1111/j.1365-2753.2009.01188.x. Epub 2009 Dec 18. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
